Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Hypertension, Primary, 2”

54 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 54 results

Not applicableStudy completedNCT03077386
What this trial is testing

Enhancing Community Health Through Patient Navigation, Advocacy and Social Support

Who this might be right for
HypertensionDiabetes Mellitus, Type 2Chronic Kidney Diseases+4 more
University of Calgary 176
Very early researchStudy completedNCT03655704
What this trial is testing

Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study

Who this might be right for
Pulmonary Arterial Hypertension
Steeve Provencher 7
Testing effectiveness (Phase 2)Looking for participantsNCT06846554
What this trial is testing

A Trial of "APL-9796'' in Adults With Pulmonary Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Apollo Therapeutics Ltd 48
Testing effectiveness (Phase 2)Ended earlyNCT04053543
What this trial is testing

CXA-10 Study in Subjects With Pulmonary Arterial Hypertension

Who this might be right for
PAH
Complexa, Inc. 33
Testing effectiveness (Phase 2)Ended earlyNCT01725269
What this trial is testing

Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05

Who this might be right for
Pulmonary Arterial Hypertension
Aires Pharmaceuticals, Inc. 17
Testing effectiveness (Phase 2)Study completedNCT03638908
What this trial is testing

Fluoxetine in Pulmonary Arterial Hypertension (PAH) Trial

Who this might be right for
Pulmonary Arterial Hypertension
University of Texas Southwestern Medical Center 8
Not applicableLooking for participantsNCT04808596
What this trial is testing

Pulmonary Hypertension Biorepository and Registry

Who this might be right for
Pulmonary HypertensionPulmonary Arterial HypertensionPulmonary Hypertension Due to Left Heart Disease+6 more
University of Kansas Medical Center 300
Post-approval studies (Phase 4)Study completedNCT03344159
What this trial is testing

Spironolactone Therapy in Chronic Stable Right HF Trial

Who this might be right for
Chronic Right-Sided Heart FailurePulmonary Arterial HypertensionPulmonary Hypertension, Primary, 2+3 more
Ottawa Heart Institute Research Corporation 15
Testing effectiveness (Phase 2)Ended earlyNCT01725256
What this trial is testing

Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Aires Pharmaceuticals, Inc. 29
Testing effectiveness (Phase 2)Study completedNCT02664558
What this trial is testing

Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)

Who this might be right for
Pulmonary Arterial Hypertension
Eiger BioPharmaceuticals 61
Testing effectiveness (Phase 2)UnknownNCT04915300
What this trial is testing

Apabetalone for Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Laval University 72
Testing effectiveness (Phase 2)Study completedNCT04712669
What this trial is testing

Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (Core OLE)

Who this might be right for
Pulmonary Arterial Hypertension
Altavant Sciences GmbH 108
Testing effectiveness (Phase 2)Study completedNCT06664801
What this trial is testing

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) (MK-7962-024)

Who this might be right for
Pulmonary Arterial Hypertension
Merck Sharp & Dohme LLC 164
Testing effectiveness (Phase 2)WithdrawnNCT06643143
What this trial is testing

IkT-001Pro in Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension (PAH)Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
Inhibikase Therapeutics
Early research (Phase 1)Study completedNCT01864863
What this trial is testing

To Compare the Pharmacokinetics of Traclear 62.5 mg Tablets and HGP1206 125mg 1 Tablet in Healthy Male Volunteers

Who this might be right for
Pulmonary Arterial Hypertension
Hanmi Pharmaceutical Company Limited 28
Testing effectiveness (Phase 2)Ended earlyNCT03449524
What this trial is testing

PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)

Who this might be right for
PAH
Complexa, Inc. 69
Large-scale testing (Phase 3)Ended earlyNCT02725372
What this trial is testing

Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH

Who this might be right for
Pulmonary Arterial Hypertension
Bellerophon Pulse Technologies 207
Testing effectiveness (Phase 2)Study completedNCT01265888
What this trial is testing

Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl.

Who this might be right for
Pulmonary Arterial HypertensionIdiopathic Pulmonary Fibrosis
Geno LLC 31
Large-scale testing (Phase 3)Not Yet RecruitingNCT07365332
What this trial is testing

An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Inhibikase Therapeutics 486
Large-scale testing (Phase 3)Study completedNCT00091598
What this trial is testing

ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Hypertension
Gilead Sciences 372
Load More Results